glutathione lightening as a skin whitening agent: Facts, myths, evidence and controversies #duet with @glowwithava FACT or

Symptoms of hypoglycemia include dizziness, sweating, confusion, and weakness

Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies

Biohacker Protocol (experimental) Dose: 0.5 1.0 mg (= 1020 clicks) Duration: 3 consecutive days Frequency: Once every 4 6 weeks Cycle Interval: 4 6 weeks off before repeating Goal / Description: Microdose pulsing investigated for cumulative senolytic effects with minimal exposure

Cognitive and Functional Gains Survivors of brain injury often struggle with memory and attention